Skip to content

Nebraska NHSN Antibiotic Use and Resistance Reporting

Nebraska NHSN Antibiotic Use and Resistance Reporting: Implementation Progress and Updates The CDC’s National Healthcare Safety Network Antimicrobial Use and…

arrow_forward

Does Piperacillin-Tazobactam Measure Up to Meropenem for ESBL Bloodstream Infections?

Extended-spectrum β-lactamase (ESBL)-producing Gram negative bacilli (GNB) have been classified by the CDC as a serious threat in its report…

arrow_forward

Implementing Antimicrobial Stewardship Efforts Across Different Healthcare Settings

 The CDC recommends implementation of antimicrobial stewardship efforts across various healthcare settings (acute, post-acute and long-term, and ambulatory care) as…

arrow_forward

Management of Common Infections in Long-Term Care

During the Nebraska Antimicrobial Stewardship Summit on June 1st, 2018, Dr. Christopher Crnich from the University of Wisconsin at Madison…

arrow_forward

New CDC Antibiotic Stewardship Training Targets Outpatient Settings

This week, CDC launched the second installment of the free web-based antibiotic stewardship training.  The first installment, which include 3…

arrow_forward

Antimicrobial Stewardship and Rapid Diagnostic Testing in Acute Care

Implementation of effective antimicrobial stewardship programs (ASP) typically requires a multipronged approach.  The Infectious Diseases Society of America (IDSA) and…

arrow_forward

What Happened at the Nebraska Antimicrobial Stewardship Summit?

After almost a year of planning, the First Annual Nebraska Antimicrobial Stewardship Summit convened on Friday, June 1st, 2018 in…

arrow_forward

Opportunities to Improve Fluoroquinolone Use in Adults Exist in Ambulatory Care Settings

Systemic fluoroquinolones* (FQ) currently in use include ciprofloxacin, levofloxacin, moxifloxacin, gemifloxacin, delafloxacin and ofloxacin.   These agents have a number of…

arrow_forward

IDSA and SHEA Update Clostridium difficile Infection Clinical Practice Guidelines

Clostridium difficile* infections (CDI) are associated with significant morbidity and mortality in the United States.  Based on data from 2006…

arrow_forward

FDA Issues New Safety Communication on Clarithromycin Use in Patients with Heart Disease

On February 22nd, the Food & Drug Administration (FDA) issued a new drug safety communication to health care providers regarding…

arrow_forward

CDC Launched Web-Based Training on Antibiotic Stewardship

In order to improve health care providers’ understanding on the threats of antibiotic resistance and the role of antibiotic stewardship…

arrow_forward

Evidence-Based Implementation Guide to Reduce Treatment of Asymptomatic Bacteriuria

Asymptomatic bacteriuria (ASB) is defined as “isolation of pre-specified quantitative count of bacteria in an appropriately collected urine specimen obtained…

arrow_forward

Antimicrobial Stewardship in the Outpatient Setting

Antimicrobial stewardship is not only about inpatient antimicrobial prescribing.  Inappropriate outpatient antibiotic prescribing has contributed to the development of resistant…

arrow_forward
Scroll To Top expand_less

Please provide your details below to reach out to our ASAP team on any questions about Antimicrobial Stewardship.

"*" indicates required fields

Address*
Name*
This field is for validation purposes and should be left unchanged.